SCHEMBL30879337

SCHEMBL30879337

COCCC(=O)N(C)c1ccc(N)c(OC)c1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
CYP3A4 P08684 2/20 0.41
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
BRAF P15056 1/20 0.38
HTT P42858 2/20 0.38
CHEK1 O14757 3/20 0.38
LMNA P02545 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
PPIB P23284 1/20 0.37
HIF1A Q16665 1/20 0.36
MET P08581 1/20 0.36
GPX4 P36969 1/20 0.36
MCHR1 Q99705 1/20 0.35
AAK1 Q2M2I8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30879349 0.86 ALDH1A1 (0.44) ALDH1A1CYP3A4TSHRHSD17B10TDP1
SCHEMBL3939407 0.83 ALDH1A1 (0.44) ALDH1A1CYP3A4TSHRHSD17B10TDP1
SCHEMBL30879400 0.83 ALDH1A1 (0.44) ALDH1A1CYP3A4TSHRHSD17B10TDP1
SCHEMBL4738078 0.79 PPIB (0.47) ALDH1A1CYP3A4TSHRTDP1BRAF
SCHEMBL30879125 0.79 LMNA (0.45) ALDH1A1TDP1HTTCHEK1LMNA
SCHEMBL30682408 0.75 ALDH1A1 (0.47) ALDH1A1CYP3A4TSHRHSD17B10TDP1
SCHEMBL520985 0.75 AURKA (0.45) CHEK1LMNAMCHR1AAK1
SCHEMBL13362035 0.74 ALDH1A1 (0.44) ALDH1A1CYP3A4TSHRHSD17B10TDP1
SCHEMBL521220 0.74 HRH3 (0.48) ALDH1A1TDP1HTTLMNAL3MBTL1
SCHEMBL27539398 0.73 ALDH1A1 (0.42) ALDH1A1CYP3A4TSHRHSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed